Immunogenicity 15861
Sample ID
None
Response
Positive
Tumor Type
Melanoma
Gene Symbol
SIRT2
Transcript ID
None
HLA INFO
A*03:01
TCR INFO
No TCR info found!
Full length protein sequence (352 aa)
MDFLR
1
NLFSQ
6
TLSLG
11
SQKER
16
LLDEL
21
TLEGV
26
ARYMQ
31
SERCR
36
RVICL
41
VGAGI
46
STSAG
51
IPDFR
56
SPSTG
61
LYDNL
66
EKYHL
71
PYPEA
76
IFEIS
81
YFKKH
86
PEPFF
91
ALAKE
96
LYPGQ
101
FKPTI
106
CHYFM
111
RLLKD
116
KGLLL
121
RCYTQ
126
NIDTL
131
ERIAG
136
LEQED
141
LVEAH
146
GTFYT
151
SHCVS
156
ASCRH
161
EYPLS
166
WMKEK
171
IFSEV
176
TPKCE
181
DCQSL
186
VKPDI
191
VFFGE
196
SLPAR
201
FFSCM
206
QSDFL
211
KVDLL
216
LVMGT
221
SLQVQ
226
PFASL
231
ISKAP
236
LSTPR
241
LLINK
246
EKAGQ
251
SDPFL
256
GMIMG
261
LGGGM
266
DFDSK
271
KAYRD
276
VAWLG
281
ECDQG
286
CLALA
291
ELLGW
296
KKELE
301
DLVRR
306
EHASI
311
DAQSG
316
AGVPN
321
PSTSA
326
SPKKS
331
PPPAK
336
DEART
341
TEREK
346
PQ
351
Mutation Information
DNA mutation:
None
Peptide Range:
175 ~ 183
Mut AA position:
None (8 in Wild Type peptide)
Alignment
Wild Type:
"KIFSEVTPK
|||||||.|
Mutant:
KIFSEVTLK"
Proc Natl Acad Sci, 2005
The response of autologous T cells to a human melanoma is dominated by mutated neoantigensGene Name (from Reference) SIRT2
Checkpoint
Blockade
None
ACT
N
Vaccination
N
Curative
Effect
None
minimal_peptide
Y
Antigen
Type
None
T-cell
Source
None
APC
Type
None
Assay
None